Dynavax Technologies Corp Announces Executive and Director Changes
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-changes, compensation
TL;DR
Dynavax is shuffling its execs and board, effective May 13th. Keep an eye on compensation details.
AI Summary
Dynavax Technologies Corporation announced on May 8, 2025, changes in its executive and director roles. The company elected new directors and appointed certain officers, alongside adjustments to compensatory arrangements for its key personnel. These changes are effective as of May 13, 2025.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial priorities, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive and director roles can introduce uncertainty regarding future strategy and operational direction.
Key Players & Entities
- Dynavax Technologies Corporation (company) — Registrant
- May 8, 2025 (date) — Date of earliest event reported
- May 13, 2025 (date) — Effective date of changes
FAQ
What specific roles were affected by the changes announced on May 8, 2025?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
When are these changes in leadership and compensation arrangements effective?
The changes are effective as of May 13, 2025.
What is the exact filing date for this 8-K report?
The filing was made on May 13, 2025.
What is Dynavax Technologies Corporation's principal executive office address?
The principal executive offices are located at 2100 Powell Street, Suite 720, Emeryville, CA 94608.
What is the Commission File Number for Dynavax Technologies Corporation?
The Commission File Number is 001-34207.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding DYNAVAX TECHNOLOGIES CORP.